Deutsche Bank Ag\ Greenwich Life Sciences, Inc. Transaction History

Deutsche Bank Ag\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$7.14 - $20.36 $15,650 - $44,629	-2,192 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$16.3 - $24.65 $4,238 - $6,409	-260 Reduced 10.6%	2,192 $43,000
Q4 2021 Feb 11, 2022	BUY	$21.76 - $39.43 $2,828 - $5,125	130 Added 5.6%	2,452 $60,000
Q3 2021 Nov 04, 2021	SELL	$38.65 - $46.11 $2,860 - $3,412	-74 Reduced 3.09%	2,322 $91,000
Q2 2021 Aug 11, 2021	BUY	$31.24 - $53.6 $74,851 - $128,425	2,396 New	2,396 $108,000

1.1M

Ticker GLSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,848,200
Market Cap $157M
Description
Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.